Atrimed Pharma plans lecture series to drive COVID-19 vaccine in India

10 August 2020 | News

Quest for a Universal COVID Vaccine The first of Lecture series - delivered by Dr. Narendra Chirmule, renowned Immunologist of vaccine

image credit: Shutterstock

image credit: Shutterstock

Bengaluru based Atrimed Pharma, a pioneer in developing scientifically-tested plant-based medication, has organized lecture series by experts ‘An Hour with an Expert’ - named “AtrimedX Platform” which will be covered in forthcoming six months, to drive COVID-19 Vaccine, its R&D pipeline momentum, productivity, and innovation.

The primary objective of the initiative in organizing the lecture series is to conglomerate renowned Experts in the field of Medicine and Pharmaceuticals to share their opinion on challenges and opportunities in the field of Drug Discovery from both development and clinical perspective and to convey the concept of plant science.

The first of the Lecture series was successfully delivered by renowned immunologist - Dr. Narendra Chirmule on the topic “Unravel the secrets of vaccine development” and received an overwhelming response with more than 900 registrations comprising of fraternity of Doctors, Scientific Community and others.”

Dr. Chirmule is the former head of research and development at Biocon Research Limited, Bengaluru and also a member of Task Force on Repurposing of Drugs (TFORD) for COVID-19 constituted by PSA to GoI. Dr. Chirmule is currently associated with Atrimed as a scientific advisor.

During his presentation, Dr. Chirmule has explained three major immune systems in humans and their role in vaccine development. In particular, he has discussed the mechanism of SARS-CoV-2 entry into the host and the immune response against the same. Further, he has briefed the characteristics of a potential vaccine for COVID-19 and the challenges associated with their clinical investigations.

Comments

× Your session has been expired. Please click here to Sign-in or Sign-up
   New User? Create Account